Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Bob and Laurie (and all)....

So many moves by this company that result in the BOD & Management being insulated from shareholders, whether it be the disclosure / effective control language in the M.A., the VSM, the VOLUNTARY change in filing status, the language regarding "change in control", etc.

To those in the "positive camp", I'm sure I'm missing the opportunities that demonstrate the converse, so PLEASE provide the contrary examples. T.I.A.

Share
New Message
Please login to post a reply